Amundi lowered its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 25.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,665,042 shares of the real estate investment trust's stock after selling 890,734 shares during the period. Amundi owned 0.38% of Healthpeak Properties worth $54,154,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp bought a new stake in Healthpeak Properties during the third quarter worth approximately $1,093,576,000. JPMorgan Chase & Co. boosted its position in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares during the period. Principal Financial Group Inc. boosted its position in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after purchasing an additional 17,314,572 shares during the period. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the third quarter worth approximately $403,898,000. Finally, Charles Schwab Investment Management Inc. boosted its position in Healthpeak Properties by 0.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust's stock worth $205,810,000 after purchasing an additional 53,392 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on DOC. Robert W. Baird decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Mizuho decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. Scotiabank decreased their target price on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research report on Friday, February 28th. Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a research report on Wednesday, January 15th. Finally, Wells Fargo & Company reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties has an average rating of "Moderate Buy" and a consensus price target of $23.92.
Get Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Down 1.8 %
Shares of DOC stock opened at $20.31 on Wednesday. The stock has a market cap of $14.20 billion, a P/E ratio of 58.02, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a one year low of $16.66 and a one year high of $23.26. The stock has a fifty day moving average price of $20.21 and a 200 day moving average price of $21.27. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35.
Healthpeak Properties Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were given a $0.305 dividend. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.01%. The ex-dividend date was Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is 348.57%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.